Drug intelligence / Profile preview

Spectral.DNC-N

Development stage
Unknown
Lead developer
DS Laboratories
Modality
Small Molecules, Nanoparticles → Drug Delivery Systems, Peptides
Administration
Topical
01

Overview

Spectral.DNC-N is a high-performance topical hair density serum developed by DS Laboratories (a subsidiary of Divine Skin) for the treatment of hair thinning and the improvement of hair density. The product's primary active ingredient is 5% Nanoxidil, a proprietary molecular compound with a lower molecular weight than minoxidil, designed to enhance absorption and efficacy while minimizing side effects. The multi-active formulation also includes caffeine, adenosine, azelaic acid, copper tripeptides, and retinol. These components are delivered via the company's proprietary Nanosome Delivery System, which encapsulates the ingredients in microscopic liposomes to ensure deep penetration and sustained release. It is marketed as a drug-free cosmetic solution that increases the appearance of hair thickness and volume, typically showing results within 90 to 180 days of twice-daily application.

Brand names
Spectral.DNC-NSpectral Men's DNC-N
Other names
Nanoxidil 5%
02

Targets

PDE (Phosphodiesterase family)ADOR (Adenosine receptors)KATP channel (ATP-sensitive potassium channel)Steroidogenesis (Steroidogenic enzymes)

Beyond the preview

Go deeper on Spectral.DNC-N.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spectral.DNC-N.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call